A Technologist’s View: Using Genetics to Define Personalized Medicine-Russ Singleton-07/26/2005 - 8:30am

Event Information
Event Topic: 
A Technologist’s View: Using Genetics to Define Personalized Medicine
Event Date: 
07/26/2005 - 8:30am
Event Location: 
NOVA
Speaker Information
Event Speaker: 
Russ Singleton
Event Speaker Title: 
VP of Engineering
Event Speaker Company: 
Perlegen Sciences
Event Speaker Bio: 

Russ Singleton is the Vice President of Engineering and Informatics at Perlegen having responsibility for the technology operation for genotyping and SNP (Single Nucleotide Polymorphism) discovery. This operation includes: chip and SNP bioinformatics, LIMS (Laboratory Information Management System) development, computation workflow development and infrastructure.

Russ Singleton has more than 25 years of technical and business leadership experience from a variety of industry sectors including biotechnology, instrumentation, and software. He was VP and GM at KLA-Tencor where he had responsibility for businesses spanning startup instrumentation, OEM hardware and software, enterprise software and consulting. Prior to KLA-Tencor, Dr. Singleton was VP of Engineering for Molecular Dynamics, a startup biotechnology discovery tools company. He led the development of multiple instrumentation and software products which were key in position the company for a successful IPO. Dr. Singleton has more than 20 years experience in engineering, marketing and strategic business development, including holding the distinction of being co-inventor for the first commercial image-processing based optical wafer inspection system. Dr. Singleton also serves on the board of a small biotech instrumentation firm as well as an advisor to a boutique M&A firm. Russell M. Singleton has a M.S and Ph.D. in Electrical Engineering from the University of Illinois, and a B. Eng. (Electrical) from Pratt Institute.

Event Details
Cost: 
$0 - Free
Event Details: 

Dr. Singleton will discuss Perlegen Sciences and its mission to use whole genome associations to uncover the genetic causes of diseases and use those associations to commercialize personalized medicines.